Explore 3 Stock Ideas & Industry Insights Download Free Report

888-969-2592
Shopping Cart 0
countryflagCA
Login

Home CompaniesGenetic Signatures Ltd

Genetic Signatures Ltd

Healthcare Diagnostics & Research
PortfolioPortfolio WatchlistWatchlist
Company price
0.071 AUD -0.01 ( 7.79%)
Last update at 2026-11-06T04:59:00Z
VOLUME
13000
Market Cap
17.49M

Momentum Score

…

Genetic Signatures Limited operates as a molecular diagnostic company in Australia, the Asia Pacific, Europe, the Middle East, Asia, and the Americas. The company offers enteric bacteria, Enteroaggregative E.coli aggR and aaiC, enteric viral, enteric protozoan, enteric protozoan extended, enteric microsporidia, respiratory pathogen, SARS-CoV-2, extended respiratory, atypical respiratory, Measles, Mumps, and Rubella detection kits under the EasyScreen name. Genetic Signatures Limited was incorporated in 2001 and is headquartered in Newtown, Australia.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
0.07
Low
0.08
High
52 Week Price Range
0.05
Low
0.34
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High
AI Summary

Genetic Signatures develops and sells molecular diagnostic assays and associated consumables for infectious disease testing, targeting clinical laboratories and public health users. Long-term growth drivers include increased demand for rapid nucleic-acid diagnostics, geographic and regulatory expansion, and recurring revenue from consumables that could support more predictable cash flows. The company may appeal to investors seeking exposure to the molecular diagnostics sector and an assay-focused business model.

Risk Score
Medium

Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.

Key Metrics*

Previous Close
0.08
Dividend Yield
-
Revenue TTM
19.33M
Revenue Per Share
0.09
Gross Profit TTM
8.61M
Debt / Equity
0.01
ROE
-32.64%
Net Debt
-8.76M
ROCE
-49.62%
Diluted EPS TTM
-0.06

Insight Announcement

View All

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2026-06-30 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Type yearly yearly yearly yearly yearly
Date 2026-06-30 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Income before tax -18.50M -20.10M -21.85M -14.05M 3.06M
Net income -14.01M -20.10M -17.86M -14.05M 3.06M
Selling general administrative - 16.07M 15.14M 15.04M 11.47M
Selling and marketing expenses - - - 1.28M 1.52M
Gross profit -12.72M 7.78M 4.31M 13.36M 23.43M
Reconciled depreciation - 2.40M 2.00M 1.53M 1.62M
Ebit -17.74M -18.48M -21.82M -14.05M 3.08M
Ebitda -15.68M -16.08M -19.82M -12.53M 4.70M
Depreciation and amortization 2.06M 2.40M 2.00M 1.53M 1.62M
Operating income -17.74M -18.48M -22.33M -14.62M 3.03M
Other operating expenses 32.20M 34.38M 30.39M 12.29M 5.35M
Interest expense 0.05M 0.09M 0.04M 0.00M 0.02M
Tax provision - 0.00M 0.00M 0.00M 0.00M
Interest income - 1.61M 0.50M 0.12M 0.13M
Net interest income - 1.52M 0.47M 0.54M 0.11M
Income tax expense -4.49M -3.85M -3.99M 0.15M 0.10M
Total revenue 14.45M 15.90M 9.77M 21.36M 35.42M
Total operating expenses 5.02M 26.26M 26.64M 28.11M 20.57M
Cost of revenue 27.18M 8.12M 5.46M 8.00M 11.99M
Total other income expense net -0.75M -1.62M 0.48M 0.15M 0.09M
Net income from continuing ops - -20.10M -17.86M -14.05M 3.06M
Net income applicable to common shares - -20.10M -17.86M -14.05M 3.06M
Breakdown 2026-06-30 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Type yearly yearly yearly yearly yearly
Date 2026-06-30 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Total assets 38.46M 54.63M 67.29M 49.08M 59.65M
Intangible assets - - - 5.49M 1.65M
Other current assets - 4.24M - 6.88M 6.88M
Total liab 2.73M 4.54M 6.18M 6.16M 4.85M
Total stockholder equity 35.72M 50.09M 61.10M 42.91M 54.80M
Other current liab 1.10M 0.84M 1.78M 2.30M 1.39M
Common stock 127.64M 127.64M 119.43M 84.44M 84.43M
Capital stock - 127.64M - 84.44M 84.43M
Retained earnings -101.12M -87.11M -67.01M -49.15M -35.09M
Other liab - - - 0.10M 0.05M
Cash 9.07M 7.47M 36.25M 16.35M 36.90M
Total current liabilities 2.70M 4.10M 5.23M 6.07M 4.80M
Current deferred revenue - - - - -0.03M
Net debt -8.76M -6.68M -35.03M -16.35M -36.86M
Short term debt 0.31M 0.88M 0.39M 0.00M 0.03M
Short long term debt total 0.31M 0.79M 1.22M - 0.03M
Other stockholder equity - - - -35.29M -49.33M
Property plant equipment - - - 7.22M 6.78M
Total current assets 35.37M 47.98M 52.55M 36.37M 51.23M
Net tangible assets - - - 37.42M 53.16M
Short term investments 13.03M 23.82M - 10.00M 25.00M
Net receivables 7.07M 3.38M 9.58M 4.39M 4.13M
Inventory 6.21M 9.06M 6.72M 8.75M 10.20M
Accounts payable 1.29M 2.38M 3.06M 3.77M 3.42M
Accumulated other comprehensive income 9.20M 9.56M 8.68M 7.62M 5.47M
Non currrent assets other - - 6.25M -12.71M -8.42M
Non current assets total 3.09M 6.66M 14.73M 12.71M 8.42M
Capital lease obligations - 0.79M - - 0.03M
Long term debt total - - - 0.00M 0.00M
Breakdown 2026-06-30 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Type yearly yearly yearly yearly yearly
Date 2026-06-30 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Investments - -24.30M -4.79M -8.09M -2.99M
Change to liabilities - - - 0.51M 0.31M
Total cashflows from investing activities 9.85M -24.30M -4.79M -8.09M -2.99M
Net borrowings - - - -0.03M -0.36M
Total cash from financing activities -0.48M 7.79M 34.81M -0.02M -0.10M
Change to operating activities - - - -4.21M 0.20M
Net income -14.01M -20.10M -17.86M -14.05M 3.06M
Change in cash 1.59M -28.78M 19.90M -20.55M 6.78M
Begin period cash flow 7.47M 36.25M 16.35M 36.90M 30.12M
End period cash flow 9.07M 7.47M 36.25M 16.35M 36.90M
Total cash from operating activities -7.77M -12.29M -10.12M -12.45M 9.81M
Issuance of capital stock - 8.77M 37.52M 0.01M 0.27M
Depreciation 2.06M - 2.00M 1.53M 1.62M
Other cashflows from investing activities - -0.25M -2.81M - -
Change to inventory 2.78M -2.75M 1.62M 1.03M 1.93M
Change to account receivables 0.45M 1.42M 2.71M 0.50M 1.24M
Sale purchase of stock - -0.55M -2.53M -0.00M -0.01M
Other cashflows from financing activities -0.48M -0.43M -0.18M -0.03M -0.36M
Change to netincome - - - 2.26M 1.44M
Capital expenditures 1.05M 0.90M 4.79M 8.09M 2.99M
Change in working capital 1.90M -2.55M 4.20M 1.52M 3.17M
Stock based compensation - - - 1.97M 1.92M
Other non cash items 2.27M -9.74M 1.55M 0.07M 5.13M
Free cash flow -8.82M -13.19M -14.91M -20.55M 6.82M

Peer Comparison*

Sector: Healthcare Industry: Diagnostics & Research

Stock Name
Change
(AUD)
Price
(AUD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
GSS
Genetic Signatures Ltd		 -0.01
7.79%		 0.07 - 52.36 0.90 0.49 1.80 -12.29
SHL
Sonic Healthcare Ltd		 0.18
0.91%		 20.06 16.16 17.21 0.90 1.15 1.36 8.10
IDX
Integral Diagnostics Ltd		 0.01
0.58%		 1.74 28.83 15.24 0.82 0.97 1.52 9.49
ACL
Australian Clinical Labs Ltd		 0.04
1.25%		 3.24 26.67 16.84 0.81 3.95 1.24 5.12
HLS
Healius Ltd		 0.01
1.01%		 0.50 - 29.24 0.26 2.08 0.94 10.14

Profile*

Genetic Signatures Ltd

Genetic Signatures Limited operates as a molecular diagnostic company in Australia, the Asia Pacific, Europe, the Middle East, Asia, and the Americas. The company offers enteric bacteria, Enteroaggregative E.coli aggR and aaiC, enteric viral, enteric protozoan, enteric protozoan extended, enteric microsporidia, respiratory pathogen, SARS-CoV-2, extended respiratory, atypical respiratory, Measles, Mumps, and Rubella detection kits under the EasyScreen name. Genetic Signatures Limited was incorporated in 2001 and is headquartered in Newtown, Australia.

Heart Research Institute, Newtown, NSW, Australia, 2042

61 2 9870 7580

https://www.geneticsignatures.com

Name Title Year Born
Dr. John R. Melki BSc, Ph.D. MD, CEO & Exec. Director NA
Mr. Peter L. Manley CPA CFO & Company Sec. NA
Mr. Michael Anton Aicher BSc, M.B.A., MBA Exec. Director of US Operations & Exec. Director 1960
Mr. Christopher M. Abbott Founder & Chairman Emeritus NA
Dr. Douglas S. Millar BSc, Ph.D. Chief Scientific Officer NA
Ms. Neralie Coulston B.Sc. Global Head of Regulatory Affairs NA
Mr. Jackson Jones B.Sc. Chief Commercial Officer NA
Dr. John R. Melki BSc, Ph.D. MD, CEO & Executive Director NA
Mr. Michael Anton Aicher BSc, M.B.A., MBA Executive Director of US Operations & Executive Director 1960
Mr. Karl David Pechmann CFO, COO & Company Secretary NA

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Kalkine

3 Mining Stock
Ideas Report

Download a free report with stock ideas and industry insights for general information.

Download Free Report Now → sector image

Top Stocks by Market Cap*

ITH
CAD 2.15
+27.68%
HG
CAD 4.11
+19.13%
PPTA
CAD 27.74
+17.99%
UCU
CAD 2.10
+17.32%
GAU
CAD 3.49
+16.72%
TSU
CAD 29.67
-29.71%
PXT
CAD 19.73
-16.91%
LAS-A
CAD 230.50
-9.25%
IFP
CAD 13.50
-8.35%
NFI
CAD 24.01
-7.80%

Equity Sectors*

  • Basic Materials

    +3.74%

  • Communication Services

    +0.56%

  • Consumer Cyclical

    -0.34%

  • Consumer Defensive

    +0.11%

  • Energy

    +1.33%

  • Financial Services

    -0.26%

  • Healthcare

    +2.54%

  • Industrials

    -0.11%

  • Real Estate

    -0.23%

  • Technology

    +1.91%

  • Utilities

    +1.05%

Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.

Support

Hi! How can we help you today?

Loading…